Pooja Purswani
Allergy & Immunology · Garland, TXNPI 1306377858
Payments from drug & device makers
Across 144 payments — averaging $22.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$708
- AstraZeneca$421
- Sanofi$341
- GSK$288
- Novartis$272
- CSL Behring$208
- plus $951 from 16 others
What the payments were for
- Food & beverage$3,11798%
- Education$742%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 29 | $708 |
| AstraZeneca | 20 | $421 |
| Sanofi | 13 | $341 |
| GSK | 16 | $288 |
| Novartis | 17 | $272 |
| CSL Behring | 8 | $208 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $201 |
| Grifols USA, LLC | 8 | $163 |
| Blueprint Medicines Corporation | 3 | $102 |
| Genentech USA, Inc. | 3 | $81 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $75 |
| Amgen | 2 | $61 |
| Lilly USA, LLC | 2 | $55 |
| Optinose US, Inc. | 2 | $44 |
| Azurity Pharmaceuticals, Inc. | 2 | $38 |
| Kaleo, Inc. | 1 | $35 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| Pfizer | 1 | $22 |
| Hospira, Inc. | 1 | $18 |
| Hikma Pharmaceuticals USA | 1 | $17 |
| AbbVie | 1 | $13 |
| Organon | 1 | $3 |
How this compares
$3,190 in reported general payments places this provider in the 35th percentile of 336 allergy & immunology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Garland
- William HowlandAustin$3.6M
- Russell PerryBeaumont$3.2M
- Barbara BaxterDallas$2.5M
- Lyndon MansfieldEl Paso$2.4M
- Dale MoharKerrville$2.3M
- Erika GonzalezSan Antonio$2.2M
- Richard WassermanDallas$1.9M
- Joseph DiazSan Antonio$1.8M
- Niran AmarWaco$840K
- Robert JacobsSan Antonio$757K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.